Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 1,836 shares at $28.01 ($51K) on 2021-10-15, disclosed to the SEC on 2021-10-19.
Scheduled sale ($51k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.01 | 1,635 | $46K | 89.1% |
| 2 | $28.00 | 201 | $6K | 10.9% |
| Total | $28.01 avg | 1,836 | $51K | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |